These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2367062)

  • 21. Synergistic action of tiazofurin and genistein in human ovarian carcinoma cells.
    Li W; Weber G
    Oncol Res; 1998; 10(3):117-22. PubMed ID: 9700722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
    Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
    Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pediatric phase I trial and pharmacokinetic study of tiazofurin (NSC 286193).
    Balis FM; Lange BJ; Packer RJ; Holcenberg JS; Ettinger LJ; Sallan SE; Heideman RL; Zimm S; Smithson WA; Cogliano-Shutta NA
    Cancer Res; 1985 Oct; 45(10):5169-72. PubMed ID: 4027992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antimetabolite Tiazofurin (TR) inhibits glycoconjugate biosynthesis and invasiveness of tumour cells.
    Tímár J; Tóvári J; Pogány G; Ladányi A; Paku S; Rśó E; Bocsi J; Jeney A; Lapis K
    Eur J Cancer; 1996 Jan; 32A(1):152-9. PubMed ID: 8695225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the progression of human and rat Wilms' tumor by Tiazofurin.
    Rásó E; Tímár J; Lapis K
    Anticancer Res; 1996; 16(6A):3333-9. PubMed ID: 9042308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I trial of tiazofurin administered by i.v. bolus daily for 5 days, with pharmacokinetic evaluation.
    Roberts JD; Stewart JA; McCormack JJ; Krakoff IR; Culham CA; Hartshorn JN; Newman RA; Haugh LD; Young JA
    Cancer Treat Rep; 1987 Feb; 71(2):141-9. PubMed ID: 3802111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FCE 27266, a sulfonic distamycin derivative, inhibits experimental and spontaneous lung and liver metastasis.
    Sola F; Farao M; Ciomei M; Pastori A; Mongelli N; Grandi M
    Invasion Metastasis; 1995; 15(5-6):222-31. PubMed ID: 8765197
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
    Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
    Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of tiazofurin on globin and proto-oncogene expression in K562 erythroleukemia cells.
    Kharbanda SM; Miyazaki K; Takeyama H; Sherman ML; Spriggs DR; Carney WP; Kufe DW
    Cancer Commun; 1989; 1(3):191-7. PubMed ID: 2639729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
    Maroun JA; Stewart DJ
    Invest New Drugs; 1990; 8 Suppl 1():S33-9. PubMed ID: 2380015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical consequences of resistance to tiazofurin in human myelogenous leukemic K562 cells.
    Jayaram HN; Zhen W; Gharehbaghi K
    Cancer Res; 1993 May; 53(10 Suppl):2344-8. PubMed ID: 8097964
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
    Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
    Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemotherapeutic sensitivity of liver metastases from intrasplenically-growing Lewis lung tumor.
    Pál K; Kopper L; Lapis K
    Clin Exp Metastasis; 1983; 1(4):341-7. PubMed ID: 6443744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase I trial and biochemical evaluation of tiazofurin administered on a weekly schedule.
    Melink TJ; Sarosy G; Hanauske AR; Phillips JL; Bayne JH; Grever MR; Jayaram HN; Von Hoff DD
    Sel Cancer Ther; 1990; 6(1):51-61. PubMed ID: 2343202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism of tiazofurin by human erythrocytes and mononuclear blood cells in vitro.
    Roberts JD; Tong WP; Hartshorn JN; Hacker MP
    Cancer Lett; 1986 Aug; 32(2):193-7. PubMed ID: 3756845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Action of 2-beta-d-Ribofuranosylthiazole-4-carboxamide (tiazofurin) in Chinese hamster ovary and variant cell lines.
    Saunders PP; Kuttan R; Lai MM; Robins RK
    Mol Pharmacol; 1983 Mar; 23(2):534-9. PubMed ID: 6188036
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiazofurin: a new antitumor agent.
    O'Dwyer PJ; Shoemaker DD; Jayaram HN; Johns DG; Cooney DA; Marsoni S; Malspeis L; Plowman J; Davignon JP; Davis RD
    Invest New Drugs; 1984; 2(1):79-84. PubMed ID: 6381381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism.
    Yang L; Huang Y; Porta R; Yanagisawa K; Gonzalez A; Segi E; Johnson DH; Narumiya S; Carbone DP
    Cancer Res; 2006 Oct; 66(19):9665-72. PubMed ID: 17018624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations in nucleoside monophosphate concentrations in 3LL tumours after combined treatment with tiazofurin and 5-hexyl-2'-deoxyuridine.
    Pogany G; Raso E; Peterszegi G; Keresztfalvi M; Lapis K; Jeney A
    Anticancer Res; 1992; 12(1):281-4. PubMed ID: 1314534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Unique bioactivation of tiazofurin--studies with resistant cells.
    Kuttan R
    Indian J Biochem Biophys; 1989 Jun; 26(3):160-5. PubMed ID: 2620910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.